1. Home
  2. OBIO vs SFBC Comparison

OBIO vs SFBC Comparison

Compare OBIO & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • SFBC
  • Stock Information
  • Founded
  • OBIO 2017
  • SFBC 1953
  • Country
  • OBIO United States
  • SFBC United States
  • Employees
  • OBIO N/A
  • SFBC N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • SFBC Savings Institutions
  • Sector
  • OBIO Health Care
  • SFBC Finance
  • Exchange
  • OBIO Nasdaq
  • SFBC Nasdaq
  • Market Cap
  • OBIO 151.3M
  • SFBC 127.6M
  • IPO Year
  • OBIO N/A
  • SFBC N/A
  • Fundamental
  • Price
  • OBIO $2.85
  • SFBC $49.94
  • Analyst Decision
  • OBIO Strong Buy
  • SFBC
  • Analyst Count
  • OBIO 5
  • SFBC 0
  • Target Price
  • OBIO $15.00
  • SFBC N/A
  • AVG Volume (30 Days)
  • OBIO 69.1K
  • SFBC 2.8K
  • Earning Date
  • OBIO 05-12-2025
  • SFBC 05-02-2025
  • Dividend Yield
  • OBIO N/A
  • SFBC 1.53%
  • EPS Growth
  • OBIO N/A
  • SFBC N/A
  • EPS
  • OBIO N/A
  • SFBC 1.80
  • Revenue
  • OBIO $2,638,000.00
  • SFBC $35,777,000.00
  • Revenue This Year
  • OBIO $27.37
  • SFBC N/A
  • Revenue Next Year
  • OBIO $42.68
  • SFBC N/A
  • P/E Ratio
  • OBIO N/A
  • SFBC $27.74
  • Revenue Growth
  • OBIO N/A
  • SFBC N/A
  • 52 Week Low
  • OBIO $2.49
  • SFBC $39.15
  • 52 Week High
  • OBIO $8.87
  • SFBC $55.99
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 36.86
  • SFBC 46.97
  • Support Level
  • OBIO $2.75
  • SFBC $49.48
  • Resistance Level
  • OBIO $3.26
  • SFBC $50.26
  • Average True Range (ATR)
  • OBIO 0.48
  • SFBC 0.87
  • MACD
  • OBIO -0.01
  • SFBC -0.07
  • Stochastic Oscillator
  • OBIO 16.82
  • SFBC 58.47

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

Share on Social Networks: